221 related articles for article (PubMed ID: 34187145)
1. Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease.
Bingöl Kızıltunç P; Büyüktepe TÇ; Yalçındağ FN; Ertem M; İnce E; İleri T; Atilla H
Turk J Ophthalmol; 2021 Jun; 51(3):134-138. PubMed ID: 34187145
[TBL] [Abstract][Full Text] [Related]
2. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
Kurt RA; Yalçindag N; Atilla H; Arat M
Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
Malta JB; Soong HK; Shtein RM; Musch DC; Rhoades W; Sugar A; Mian SI
Cornea; 2010 Dec; 29(12):1392-6. PubMed ID: 20847658
[TBL] [Abstract][Full Text] [Related]
4. Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.
Giannaccare G; Bonifazi F; Sessa M; Dan E; Arpinati M; Fresina M; Bandini G; Cavo M; Versura P; Campos EC
Eye (Lond); 2017 Oct; 31(10):1417-1426. PubMed ID: 28524885
[TBL] [Abstract][Full Text] [Related]
5. Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination.
Giannaccare G; Versura P; Bonifazi F; Sessa M; Campos EC
Eye (Lond); 2019 Jan; 33(1):154-160. PubMed ID: 30194377
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
Rao SN; Rao RD
Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
[TBL] [Abstract][Full Text] [Related]
7. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
8. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
Fahnehjelm KT; Törnquist AL; Winiarski J
Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of lipid layer thickness of tear film in the diagnosis of dry-eye syndrome in children after the hematopoietic stem cell transplantation].
Kurpińska M; Gorczyńska E; Owoc-Lempach J; Bernacka A; Misiuk-Hojło M; Chybicka A
Klin Oczna; 2011; 113(4-6):136-40. PubMed ID: 21913442
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and correlative factors of dry eye disease associated with graft-versus-host disease].
Zhuang XY; Sun ZT; Wang YM; Que LJ; Zhang XF
Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):295-301. PubMed ID: 37012593
[No Abstract] [Full Text] [Related]
11. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.
Wang Y; Ogawa Y; Dogru M; Tatematsu Y; Uchino M; Kamoi M; Okada N; Okamoto S; Tsubota K
Bone Marrow Transplant; 2010 Jun; 45(6):1077-83. PubMed ID: 19898506
[TBL] [Abstract][Full Text] [Related]
12. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
[TBL] [Abstract][Full Text] [Related]
13. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic cyclosporine use in ocular GVHD.
Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
[TBL] [Abstract][Full Text] [Related]
15. [Corneal complications after hematopoietic stem cell transplantation].
Mittelviefhaus H; Auw-Hädrich C
Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
[TBL] [Abstract][Full Text] [Related]
16. Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease.
Shimizu E; Ogawa Y; Saijo Y; Yamane M; Uchino M; Kamoi M; Fukui M; Yang F; He J; Mukai S; Tsubota K
Ocul Surf; 2019 Apr; 17(2):265-271. PubMed ID: 30742990
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops.
Sanz-Marco E; Udaondo P; García-Delpech S; Vazquez A; Diaz-Llopis M
J Ocul Pharmacol Ther; 2013 Oct; 29(8):776-83. PubMed ID: 23947579
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
Schargus M; Meyer-ter-Vehn T; Menrath J; Grigoleit GU; Geerling G
Cornea; 2015 Aug; 34(8):911-6. PubMed ID: 26075459
[TBL] [Abstract][Full Text] [Related]
19. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
[TBL] [Abstract][Full Text] [Related]
20. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
